4.0 Review

Recommendations for Pathology Peer Review

Journal

TOXICOLOGIC PATHOLOGY
Volume 38, Issue 7, Pages 1118-1127

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/0192623310383991

Keywords

audit trail; pathology; peer review; quality

Funding

  1. Society of Toxicologic Pathology
  2. European Society of Toxicologic Pathology
  3. Japanese Society of Toxicologic Pathology
  4. British Society of Toxicologic Pathologists
  5. French Society of Toxicologic Pathology
  6. Italian Society of Toxicologic and Experimental Pathology
  7. Society of Toxicologic Pathology-India
  8. Korean Society of Toxicologic Pathology
  9. Latin American Society of Toxicologic Pathology
  10. American College of Veterinary Pathologists

Ask authors/readers for more resources

Pathology peer review verifies and improves the accuracy and quality of pathology diagnoses and interpretations. Pathology peer review is recommended when important risk assessment or business decisions are based on nonclinical studies. For pathology peer review conducted before study completion, the peer-review pathologist reviews sufficient slides and pathology data to assist the study pathologist in refining pathology diagnoses and interpretations. Materials to be reviewed are selected by the peer-review pathologist. Consultations with additional experts or a formal (documented) pathology working group may be used to resolve discrepancies. The study pathologist is solely responsible for the content of the final pathology data and report, makes changes resulting from peer-review discussions, initiates the audit trail for microscopic observations after all changes resulting from peer-review have been made, and signs the final pathologist's report. The peer-review pathologist creates a signed peer-review memo describing the peer-review process and confirming that the study pathologist's report accurately and appropriately reflects the pathology data. The study pathologist also may sign a statement of consensus. It is not necessary to archive working notes created during the peer-review process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation

Martijn P. Lolkema, Hilde H. Bohets, Hendrik-Tobias Arkenau, Ann Lampo, Erio Barale, Maja J. A. de Jonge, Leni van Doorn, Peter Hellemans, Johann S. de Bono, Ferry A. L. M. Eskens

CLINICAL CANCER RESEARCH (2015)

Review Pathology

International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies

Brad Bolon, Erio Barale-Thomas, Alys Bradley, Robert A. Ettlin, Carla A. S. Franchi, Catherine George, Anna Maria Giusti, Robert Hall, Matthew Jacobsen, Yoichi Konishi, David Ledieu, Daniel Morton, Jae-Hak Park, Cheryl L. Scudamore, Hiroyuki Tsuda, S. K. Vijayasarathi, Marcel V. W. Wijnands

EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2011)

Letter Pathology

A commentary on the process of peer review and pathology data locking

Jennifer S. McKay, Erio Barale-Thomas, Brad Bolon, Catherine George, Jerry Hardisty, Sunao Manabe, Frederic Schorsch, Munehiro Teranishi, Klaus Weber

EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2011)

Letter Food Science & Technology

Serious inadequacies regarding the pathology data presented in the paper by Seralini et al. (2012)

Erio Barale-Thomas

FOOD AND CHEMICAL TOXICOLOGY (2013)

Editorial Material Pathology

A Commentary on the Process of Peer Review and Pathology Data Locking

Jennifer S. McKkay, Erio Barale-Thomas, Brad Bolon, Catherine George, Jerry Hardisty, Sunao Manabe, Frederic Schorsch, Munehiro Teranishi, Klaus Weber

TOXICOLOGIC PATHOLOGY (2010)

Article Pathology

International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-type, Nonclinical Toxicity Studies

Brad Bolon, Erio Barale-Thomas, Alys Bradley, Robert A. Ettlin, Carla A. S. Franchi, Catherine George, Anna Maria Giusti, Robert Hall, Matthew Jacobsen, Yoichi Konishi, David Ledieu, Daniel Morton, Jae-Hak Park, Cheryl L. Scudamore, Hiroyuki Tsuda, S. K. Vijayasarathi, Marcel V. W. Wijnands

TOXICOLOGIC PATHOLOGY (2010)

Article Pathology

Tissue Kim-1 and Urinary Clusterin as Early Indicators of Cisplatin-Induced Acute Kidney Injury in Rats

Petra Vinken, Sofie Starckx, Erio Barale-Thomas, Adriana Looszova, Manisha Sonee, Nick Goeminne, Loes Versmissen, Kristel Buyens, Ann Lampo

TOXICOLOGIC PATHOLOGY (2012)

Article Cell Biology

Reproducing human and cross-species drug toxicities using a Liver-Chip

Kyung-Jin Jang, Monicah A. Otieno, Janey Ronxhi, Heng-Keang Lim, Lorna Ewart, Konstantia R. Kodella, Debora B. Petropolis, Gauri Kulkarni, Jonathan E. Rubins, David Conegliano, Janna Nawroth, Damir Simic, Wing Lam, Monica Singer, Erio Barale, Bhanu Singh, Manisha Sonee, Anthony J. Streeter, Carl Manthey, Barry Jones, Abhishek Srivastava, Linda C. Andersson, Dominic Williams, Hyoungshin Park, Riccardo Barrile, Josiah Sliz, Anna Herland Section, Suzzette Haney, Katia Karalis, Donald E. Ingber, Geraldine A. Hamilton

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Pathology

Unusual Incidence and Location of Renaut Bodies in Beagle Dogs in a Nonclinical Study

Sophie Nelissen, Joost Lensen, Erio Barale-Thomas

TOXICOLOGIC PATHOLOGY (2020)

Article Pathology

The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019)

Vanessa L. Schumacher, Famke Aeffner, Erio Barale-Thomas, Catherine Botteron, Jonathan Carter, Laetitia Elies, Jeffery A. Engelhardt, Pierluigi Fant, Thomas Forest, Peter Hall, Deon Hildebrand, Robert Klopfleisch, Thomas Lucotte, Heike Marxfeld, LuAnn Mckinney, Pierre Moulin, Elizabeth Neyens, Xavier Palazzi, Alain Piton, Elena Riccardi, Daniel R. Roth, Serge Rousselle, Justin D. Vidal, Bethany Williams

Summary: Advancements in digital pathology have led to increased adoption in human medical pathology, but challenges remain in toxicologic pathology, particularly in regulatory studies. International workshops are being held to assess current applications, challenges, and outline minimal requirements for gaining regulatory acceptance in toxicologic pathology workflows.

TOXICOLOGIC PATHOLOGY (2021)

Article Pathology

IMI-Bigpicture: A Central Repository for Digital Pathology

Pierre Moulin, Katrien Grunberg, Erio Barale-Thomas, Jeroen van der Laak

Summary: The goal of the project is to drive digital transformation in pathology by establishing a whole slide imaging platform, connecting pathologists, researchers, AI developers, patients, and industry participants, with an emphasis on sustainable development and reciprocal cooperation.

TOXICOLOGIC PATHOLOGY (2021)

Article Pathology

Evaluation of the Use of Single- and Multi-Magnification Convolutional Neural Networks for the Determination and Quantitation of Lesions in Nonclinical Pathology Studies

Jogile Kuklyte, Jenny Fitzgerald, Sophie Nelissen, Haolin Wei, Aoife Whelan, Adam Power, Ajaz Ahmad, Martyna Miarka, Mark Gregson, Michael Maxwell, Ruka Raji, Joseph Lenihan, Eve Finn-Moloney, Mairin Rafferty, Maurice Cary, Erio Barale-Thomas, Donal O'Shea

Summary: The integration of digital pathology platforms with artificial intelligence has the potential to enhance workflow efficiency for nonclinical pathologists by screening slides with lesions and highlighting areas with specific lesions. This study compared single- and multi-magnification convolutional neural network architectures for detecting lesions in tissues, evaluating performance characteristics across key rat organs. The use of CNN-based models allows for generalized lesion detection in whole-slide images, potentially generating novel quantitative data.

TOXICOLOGIC PATHOLOGY (2021)

Article Neurosciences

Passive immunotherapy with a novel antibody against 3pE-modified A? demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice

Jonathan Janssens, Bart Hermans, Marc Vandermeeren, Erio Barale-Thomas, Marianne Borgers, Roland Willems, Greet Meulders, Cindy Wintmolders, Dries Van den Bulck, Astrid Bottelbergs, Luc Ver Donck, Peter Larsen, Dieder Moechars, Wilson Edwards, Marc Mercken, Bianca Van Broeck

Summary: The imbalance between production and clearance of Aβ peptides is a crucial step in AD pathogenesis, making Aβ a promising therapeutic target. Research has shown that a high-affinity antibody targeting Aβ peptides with a pyroglutamate residue at amino acid position 3 can significantly reduce amyloid burden in mouse brains. Furthermore, combining this antibody treatment with chronic BACE1 inhibitor treatment leads to significant clearance of pre-existing amyloid deposits in the brain without inducing microhemorrhages or other histopathological findings.

NEUROBIOLOGY OF DISEASE (2021)

Article Pharmacology & Pharmacy

JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms

Florence Herschke, Chris Li, Ren Zhu, Qinglin Han, Qun Wu, Qing Lu, Erio Barale-Thomas, Sandra De Jonghe, Tse- Lin, An De Creus

Summary: JNJ-64794964, an oral toll-like receptor 7 agonist, shows promising anti-hepatitis B activity by significantly reducing HBV DNA and surface antigen levels, inducing antibody and specific T cell production, and promoting cytokine-mediated, non-cytolytic mechanisms. This drug has the potential to improve immune response, reduce liver damage and inflammation compared to traditional treatments for chronic hepatitis B.

ANTIVIRAL RESEARCH (2021)

Article Pathology

IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop

Julie Boisclair, Bhupinder Bawa, Erio Barale-Thomas, Lise Bertrand, Jonathan Carter, Richard Crossland, Celine Dorn, Thomas Forest, Sabine Grote, Anja Gilis, Deon Hildebrand, Brian Knight, Sebastien Laurent, Heike Antje Marxfeld, Steen Jorgen Ostergaard, Thibault Roguet, Thorsten Schlueter, Vanessa Schumacher, Richard Spehar, William Varady, Christian Zeugin

Summary: Digital toxicologic histopathology is widely used in preclinical compound development and there is increasing interest in implementing it for good laboratory practice-regulated study evaluations. However, implementation is not straightforward due to the need for qualification, validation, and security considerations. The European Society of Toxicologic Pathology organized an international expert workshop to discuss qualification and validation of digital histopathology systems in a good laboratory practice environment.

TOXICOLOGIC PATHOLOGY (2022)

No Data Available